SacredBod
0
Dihexa (Nootropic Peptide) — SacredBod supplement bottle (illustrative)
Supplement · Nootropic & Peptide

Dihexa (Nootropic Peptide)

As directed · vegan · gluten-free · 60 caps

memory-loss brain
Find on Amazon →

Affiliate link · we earn from qualifying purchases. No paid placements.

What it is

Dihexa (Nootropic Peptide) is a nootropic & peptide supplement. Dihexa is a small angiotensin-IV-derived peptide studied for exceptionally potent synapse formation in preclinical work. Used in adult dosing protocols in India and internationally, it is sold as a single-ingredient supplement.

How it works

It augments hepatocyte-growth-factor/c-Met signalling to drive synaptogenesis (new synapse formation) far more potently than BDNF in laboratory models. Effects are dose-dependent and typically measurable within weeks.

Who should take it

Adults exploring experimental synaptogenic peptides; evidence is preclinical only.

Avoid / careful

Research-grade with NO human safety data; potent growth signalling raises theoretical cancer concern. Avoid in pregnancy/cancer; consult a clinician.

When to take it

Morning
Noon
Evening
Night

How to take it

With food
Empty stomach
Before food

Flexible — works in any of the above.

FAQs

Frequently asked

What is the primary mechanism of action for Dihexa?
Dihexa works by enhancing the HGF/c-Met signaling pathway, which is crucial for synaptogenesis, the formation of new synapses in the brain.
Is Dihexa safe for human consumption?
Human safety data for Dihexa is limited as most evidence comes from preclinical studies. Theoretical concerns exist regarding its potent growth signaling effects, particularly in individuals with a history of cancer.
How quickly can I expect to see results from Dihexa?
In preclinical models, effects of Dihexa have been observed to be dose-dependent and typically measurable within a few weeks of consistent use.

Editorial notes

SacredBod's longer take on Dihexa (Nootropic Peptide) — context the structured blocks above don't capture.

About Dihexa (Nootropic Peptide)

Angiotensin-derived peptide studied for potent synaptogenesis..

How it works

It augments hepatocyte-growth-factor/c-Met signalling to drive synaptogenesis (new synapse formation) far more potently than BDNF in laboratory models. Effects are dose-dependent and typically measurable within weeks.

Who it’s for

Adults exploring experimental synaptogenic peptides; evidence is preclinical only.

Dosage & timing

  • Typical dose: As directed
  • Best time: morning
  • With food: flexible
  • Expected onset: Weeks.

Safety

Research-grade with NO human safety data; potent growth signalling raises theoretical cancer concern. Avoid in pregnancy/cancer; consult a clinician.

Added to your stack.